SOW
ITCI

State of Wyoming’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

State of Wyoming’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,421
Closed -$119K – 1893
2024
Q4 		$119K Sell
1,421
-23
-2% -$1.89K 0.02% 1098
2024
Q3 		$106K Sell
1,444
-82
-5% -$6.16K 0.02% 1090
2024
Q2 		$105K Buy
1,526
+169
+12% +$11.7K 0.02% 987
2024
Q1 		$93.9K Sell
1,357
-88
-6% -$6.05K 0.02% 1046
2023
Q4 		$103K Buy
1,445
+181
+14% +$10.4K 0.02% 954
2023
Q3 		$65.8K Buy
1,264
+413
+49% +$24.1K 0.01% 1131
2023
Q2 		$53.9K Buy
851
+312
+58% +$19.4K 0.02% 1133
2023
Q1 		$29.2K Buy
539
+15
+3% +$725 0.01% 1295
2022
Q4 		$27.7K Buy
524
+100
+24% +$5.01K 0.01% 1268
2022
Q3 		$20K Sell
424
-11
-3% -$575 0.01% 1332
2022
Q2 		$25K Sell
435
-972
-69% -$55.1K 0.02% 1358
2022
Q1 		$86K Buy
+1,407
New +$73.1K 0.04% 710

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

State of Wyoming's ITCI Position: Q1 2025 in Review

State of Wyoming sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 1,421 shares — an estimated $119K sold.

State of Wyoming first reported a position in ITCI in Q1 2022 and held it in 12 quarters. The position peaked at $119K in Q4 2024. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • State of Wyoming reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • State of Wyoming sold 1,421 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $119K.
  • State of Wyoming first reported a position in Intra-Cellular Therapies Inc. in Q1 2022 and held it in 12 quarters.
  • State of Wyoming's Intra-Cellular Therapies Inc. position peaked at $119K in Q4 2024.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on State of Wyoming's 13F filing for Q1 2025, filed 14 May 2025.